Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Gains from Sales and Divestitures (2022)

Historic Gains from Sales and Divestitures for Agilon Health (AGL) over the last 1 years, with Q4 2022 value amounting to $404000.0.

  • Agilon Health's Gains from Sales and Divestitures changed N/A to $404000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $404000.0, marking a year-over-year change of. This contributed to the annual value of $404000.0 for FY2022, which is N/A changed from last year.
  • Per Agilon Health's latest filing, its Gains from Sales and Divestitures stood at $404000.0 for Q4 2022.
  • Over the past 5 years, Agilon Health's Gains from Sales and Divestitures peaked at $404000.0 during Q4 2022, and registered a low of $404000.0 during Q4 2022.